FDA Approves Tirzepatide for Obstructive Sleep Apnea
Tirzepatide significantly reduced obstructive sleep apnea severity and body weight in adults with obesity, supporting FDA-approved treatment alongside lifestyle changes and PAP therapy.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.